Half-year report · HY
6951.TEDINET S100X4AK
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥82.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥196.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥87.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥11.9bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥15.8bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥12.9bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥34.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥14.1bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥13.9bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥14.1bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥9.8bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥18.7bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥10.9bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥9.8bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥10.9bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥226.5bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥222.5bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥229.7bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥82.7bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥85.8bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥143.8bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥136.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥131.6bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥36.0bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥36.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥34.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.6bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥37.7bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥9.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥17.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥855m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥5.9bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥17.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥7.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥192.55 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥365.55 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥213.6 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 63.5% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.3% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥3.2bn |
| Industrial Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥27.0bn |
| Industrial Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥27.0bn |
| Industrial Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥11.7bn |
| Medical Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥7.4bn |
| Medical Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥7.4bn |
| Medical Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥696m |
| Scientific And Measurement Instrumentsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥47.7bn |
| Scientific And Measurement Instrumentsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥47.7bn |
| Scientific And Measurement Instrumentsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥2.7bn |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥82.1bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥82.1bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥15.1bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥3.2bn |
| Industrial Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥28.7bn |
| Industrial Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥28.7bn |
| Industrial Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.6bn |
| Medical Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥6.4bn |
| Medical Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥6.4bn |
| Medical Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥394m |
| Scientific And Measurement Instrumentsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥52.2bn |
| Scientific And Measurement Instrumentsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥52.2bn |
| Scientific And Measurement Instrumentsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥4.0bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥87.2bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥87.2bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥19.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 533
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of treasury stock fin cf | Prior1InterimDuration | -0 | JPY |
| Purchase of treasury stock fin cf | InterimDuration | － | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -3538000000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -3186000000 | JPY |
| Other net fin cf | Prior1InterimDuration | -209000000 | JPY |
| Other net fin cf | InterimDuration | -236000000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | -7487000000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -5905000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1InterimDuration | -340000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | InterimDuration | 650000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | 7856000000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | -295000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 29807000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 34605000000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 37663000000 | JPY |
| Cash and cash equivalents | InterimInstant | 34309000000 | JPY |
| Salaries and allowances sga | Prior1InterimDuration | 8395000000 | JPY |
| Salaries and allowances sga | InterimDuration | 8802000000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 540000000 | JPY |
| Provision for bonuses sga | InterimDuration | 569000000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 251000000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 246000000 | JPY |
| Provision for directors retirement benefits sga | Prior1InterimDuration | 8000000 | JPY |
| Provision for directors retirement benefits sga | InterimDuration | 15000000 | JPY |
| Provision for share based remuneration for directors and other officers sga | Prior1InterimDuration | 64000000 | JPY |
| Provision for share based remuneration for directors and other officers sga | InterimDuration | 45000000 | JPY |
| Depreciation sga | Prior1InterimDuration | 835000000 | JPY |
| Depreciation sga | InterimDuration | 931000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E01905-000ScientificAndMeasurementInstrumentsReportableSegmentsMember | 52168000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E01905-000IndustrialEquipmentReportableSegmentsMember | 28654000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E01905-000MedicalEquipmentReportableSegmentsMember | 6411000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReportableSegmentsMember | 87234000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 87234000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E01905-000ScientificAndMeasurementInstrumentsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E01905-000IndustrialEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E01905-000MedicalEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E01905-000ScientificAndMeasurementInstrumentsReportableSegmentsMember | 52168000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E01905-000IndustrialEquipmentReportableSegmentsMember | 28654000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E01905-000MedicalEquipmentReportableSegmentsMember | 6411000000 | JPY |
| Net sales | Prior1InterimDuration_ReportableSegmentsMember | 87234000000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1InterimDuration | 87234000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E01905-000ScientificAndMeasurementInstrumentsReportableSegmentsMember | 4032000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E01905-000IndustrialEquipmentReportableSegmentsMember | 14622000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E01905-000MedicalEquipmentReportableSegmentsMember | 394000000 | JPY |
| Operating income | Prior1InterimDuration_ReportableSegmentsMember | 19049000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |